DuoNeb
What is COPD?
Do I Have COPD?
Treatment Options
The DuoNeb Advantage
FAQs
Getting the Best Results
Talking to Your Doctor
Patient Testimonials
Substitution
Prescibing Information
Living Better with COPD
Resources
What people like you are saying about DuoNeb®
"Since I have been using my nebulizer, it has opened up a new world for my ability to breathe freely."
- Irving L.
"I never felt I reached the 'whole lung' with an inhaler, and using ipratropium (Atrovent®) didn't give me the push I needed. Adding albuterol to ipratropium when I nebulized made my nebulizing treatment too long, but when I started using DuoNeb®, I was able to give my lungs the push they needed, in about the same time it took me to nebulize with albuterol alone.
If you want to get your medications down deep into your lungs, nebulize.
DuoNeb® allows you to combine the benefits of albuterol and ipratropium with one vial of a nebulizing treatment -- fast and effective. I like to think of it as 'one-stop shopping."
- Mary K.
"I have been on DuoNeb® for a year now and it has helped my life a lot. When I started treatment, I was nebulizing four times a day. Now I am nebulizing only twice a day. The supplemental information I receive is also very helpful."
- Joseph P.
SAFETY INFORMATION   .   PATIENT PRESCRIBING INFORMATION   .   FULL PRESCRIBING INFORMATION
  .   CONTACT US   .   REFERENCES   .   SITE MAP
Please read this important safety information about DuoNeb®
DuoNeb® is indicated for the treatment of bronchospasm associated with COPD for patients requiring more than one bronchodilator. In a 12-week clinical study, the most common adverse reactions reported with DuoNeb® Inhalation Solution were chest pain, pharyngitis, diarrhea, bronchitis, nausea, and leg cramps.
Albuterol sulfate can have a significant cardiovascular effect, significant hypokalemia, and the potential life-threatening paradoxical bronchospasm. Caution is advised in patients with convulsive disorders, hyperthyroidism, diabetes mellitus, narrow-angle glaucoma, prostatic hypertrophy, or bladder-neck obstruction. Co-administration of DuoNeb® Inhalation Solution and other sympathomimetic agents may increase the risk of adverse cardiovascular effects.